Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.09 | 1.00 | -1.34 | 3.71 |
| FCF Yield | -2.54% | 1.17% | 4.65% | 3.49% |
| EV / EBITDA | 13.53 | 12.11 | 16.61 | 21.33 |
| Quality | ||||
| ROIC | 11.50% | 12.05% | 9.81% | 16.76% |
| Gross Margin | 68.34% | 71.15% | 69.42% | 72.93% |
| Cash Conversion Ratio | 1.37 | 1.25 | 1.48 | 1.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.11% | 9.64% | 8.55% | 2.16% |
| Free Cash Flow Growth | -375.58% | -72.07% | -9.63% | 48.69% |
| Safety | ||||
| Net Debt / EBITDA | -0.38 | -0.17 | 2.56 | 1.29 |
| Interest Coverage | 7.83 | 7.45 | 12.70 | 23.45 |
| Efficiency | ||||
| Inventory Turnover | 1.46 | 1.48 | 1.34 | 1.87 |
| Cash Conversion Cycle | 187.98 | 167.84 | 199.68 | 114.45 |